CLINICAL_TRIALS
guidance
· 2024-07-03
Clinical Trial Update: Strategies for Adaptive Follow-up and Evaluation - Guiding Use of Indicators for De-Escalation in Multiple Sclerosis
Summary
This document outlines strategies for adaptive follow-up and evaluation and provides guidance on when to de-escalate MS treatment based on specific clinical ind…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Heinrich-Heine University, Duesseldorf | Conditions: Multiple Sclerosis | Status: RECRUITING